Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

A new ER-specific photosensitizer unravels (1)O2-driven protein oxidation and inhibition of deubiquitinases as a generic mechanism for cancer PDT.

Pinto A, Mace Y, Drouet F, Bony E, Boidot R, Draoui N, Lobysheva I, Corbet C, Polet F, Martherus R, Deraedt Q, Rodríguez J, Lamy C, Schicke O, Delvaux D, Louis C, Kiss R, Kriegsheim AV, Dessy C, Elias B, Quetin-Leclercq J, Riant O, Feron O.

Oncogene. 2016 Jul 28;35(30):3976-85. doi: 10.1038/onc.2015.474. Epub 2015 Dec 21.

PMID:
26686091
2.

Activity-Fed Translation (AFT) Assay: A New High-Throughput Screening Strategy for Enzymes in Droplets.

Woronoff G, Ryckelynck M, Wessel J, Schicke O, Griffiths AD, Soumillion P.

Chembiochem. 2015 Jun 15;16(9):1343-9. doi: 10.1002/cbic.201500087. Epub 2015 May 7.

PMID:
25914325
3.

Antitumor activity of 7-aminocarboxycoumarin derivatives, a new class of potent inhibitors of lactate influx but not efflux.

Draoui N, Schicke O, Seront E, Bouzin C, Sonveaux P, Riant O, Feron O.

Mol Cancer Ther. 2014 Jun;13(6):1410-8. doi: 10.1158/1535-7163.MCT-13-0653. Epub 2014 Mar 26.

4.

Synthesis and pharmacological evaluation of carboxycoumarins as a new antitumor treatment targeting lactate transport in cancer cells.

Draoui N, Schicke O, Fernandes A, Drozak X, Nahra F, Dumont A, Douxfils J, Hermans E, Dogné JM, Corbau R, Marchand A, Chaltin P, Sonveaux P, Feron O, Riant O.

Bioorg Med Chem. 2013 Nov 15;21(22):7107-17. doi: 10.1016/j.bmc.2013.09.010. Epub 2013 Sep 13.

PMID:
24095010
5.

New generation of amino coumarin methyl sulfonate-based fluorogenic substrates for amidase assays in droplet-based microfluidic applications.

Woronoff G, El Harrak A, Mayot E, Schicke O, Miller OJ, Soumillion P, Griffiths AD, Ryckelynck M.

Anal Chem. 2011 Apr 15;83(8):2852-7. doi: 10.1021/ac200373n. Epub 2011 Mar 17.

PMID:
21413778

Supplemental Content

Loading ...
Support Center